vimarsana.com
Home
Live Updates
Sterling Stands to Benefit From Higher Rates -2- : vimarsana
Sterling Stands to Benefit From Higher Rates -2- : vimarsana
Sterling Stands to Benefit From Higher Rates -2-
1149 GMT - Sales of GSK's respiratory syncytial virus vaccine Arexvy are expected to peak at $4 billion and could surpass consensus, Jefferies analysts say in a note. This drug, together with... | May 30, 2023
Related Keywords
Germany ,
Canada ,
United Kingdom ,
German ,
British ,
Matthew Chadwick ,
Jack Cummings ,
Haley Tam ,
Mark Wilson ,
Darren Shirley ,
Jamie Franklin ,
Credit Suisse ,
Hollywood Bowl Group ,
Fund Management Company ,
Hunting New Order Underpins Robust International Outlook ,
Group Better ,
Greencore ,
Capital Group ,
Shore Capital ,
Clive Black ,
Intermediate Capital Group ,
Elvis Anoma Amoabeng ,
Reaffirms Prospects ,
Bowl Group ,
Shows Value ,
Canada Performance Makes ,
Hollywood Bowl ,
Russ Mould ,
London Newsplus ,
Dow Jones Newswires ,
Dow Jones ,
Hollywood Bowl Group Plc Stock Exchange ,
News ,
Information ,
Press Release ,
149 ,
Mt ,
Sales ,
F ,
Espiratory ,
Syncytial ,
Virus ,
Vaccine ,
Arexvy ,
Fire ,
Xpected ,
O ,
Beak ,
It ,
Billion ,
End ,
Would ,
Urpass ,
Efferies ,
Analysts ,
Bay ,
N ,
This ,
Ogether Bowl Gb00bd0nvk62 ,